Filing Details

Accession Number:
0001387131-19-006905
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-12 16:18:46
Reporting Period:
2019-09-10
Accepted Time:
2019-09-12 16:18:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1595893 Turning Point Therapeutics Inc. TPTX Pharmaceutical Preparations (2834) X0
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1131399 Plc Glaxosmithkline 980 Great West Road
Brentford Middlesex X0 TW8 9GS
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-10 177,777 $45.00 2,170,327 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. S.R. One, Limited purchased 177,777 shares of Common Stock of Turning Point Therapeutics, Inc (the "Issuer") in connection with the Issuer's public offering.
  2. The shares reported herein are held of record by S.R. One, Limited, an indirect, wholly-owned subsidiary of GlaxoSmithKline plc (the "Reporting Person").